6-(1-methylpyrazol-4-yl)-4-(2-piperazin-1-ylpyrimidin-5-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile;dihydrochloride
C20H21Cl2N9 — CID 135150240
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(1-methylpyrazol-4-yl)-4-(2-piperazin-1-ylpyrimidin-5-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile;dihydrochloride
6-(1-methylpyrazol-4-yl)-4-(2-piperazin-1-ylpyrimidin-5-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile;dihydrochloride (PubChem CID 135150240) has the molecular formula C20H21Cl2N9 and a molecular weight of 458.36 g/mol. Its IUPAC name is 6-(1-methylpyrazol-4-yl)-4-(2-piperazin-1-ylpyrimidin-5-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile;dihydrochloride.
Molecular Properties
| Compound Name | 6-(1-methylpyrazol-4-yl)-4-(2-piperazin-1-ylpyrimidin-5-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile;dihydrochloride |
|---|---|
| PubChem CID | 135150240 |
| Molecular Formula | C20H21Cl2N9 |
| Molecular Weight | 458.36 g/mol |
| Exact Mass | 457.13 |
| IUPAC Name | 6-(1-methylpyrazol-4-yl)-4-(2-piperazin-1-ylpyrimidin-5-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile;dihydrochloride |
| SMILES | Cl.Cl.Cn1cc(-c2cc(-c3cnc(N4CCNCC4)nc3)c3c(C#N)cnn3c2)cn1 |
| InChI | InChI=1S/C20H19N9.2ClH/c1-27-12-17(11-25-27)14-6-18(19-15(7-21)10-26-29(19)13-14)16-8-23-20(24-9-16)28-4-2-22-3-5-28;;/h6,8-13,22H,2-5H2,1H3;2*1H |
| InChIKey | RDFTXKOXSFLUGX-UHFFFAOYSA-N |
| XLogP | 2.32 |
| TPSA | 99.96 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 458.36 |
| LogP ≤ 5 | 2.32 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135150240 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.